Practice Test Geeks(PPC) Patent Paralegal Certification Practice Test
← All PPC Flashcard Decks

Regulatory Compliance & Legal Framework Flashcards

7 cards from real PPC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Regulatory Compliance & Legal Framework flashcards as text

  1. Under 37 CFR 1.56, which of the following parties has a duty of candor and good faith toward the USPTO?

    Answer: Each individual associated with filing or prosecution of the application

    37 CFR 1.56 imposes the duty of candor on each individual associated with the filing or prosecution of a patent application, including inventors, attorneys, and patent paralegals.

  2. A patent paralegal discovers a prior art reference that may be material to patentability after filing. What is the proper course of action?

    Answer: Immediately notify the supervising attorney so an IDS can be filed

    Newly discovered material prior art must be disclosed via an Information Disclosure Statement (IDS), and the paralegal must notify the supervising attorney to initiate that process.

  3. Which USPTO regulation governs the requirements for small entity status, allowing reduced patent fees?

    Answer: 37 CFR 1.27

    37 CFR 1.27 defines the criteria and procedures for establishing small entity status to qualify for reduced USPTO fees.

  4. What is the consequence of an applicant incorrectly claiming small entity status when paying USPTO fees?

    Answer: The applicant must pay the difference plus a surcharge and any applicable interest

    Incorrectly claiming small entity status requires payment of the fee deficiency plus any applicable surcharge to avoid inequitable conduct issues.

  5. Under the America Invents Act (AIA), which proceeding replaced inter partes reexamination?

    Answer: Inter partes review (IPR)

    The AIA replaced inter partes reexamination with inter partes review (IPR), a trial proceeding before the Patent Trial and Appeal Board.

  6. A patent application claiming a pharmaceutical compound must include which type of disclosure to satisfy 35 U.S.C. 112?

    Answer: A written description, enablement, and best mode

    35 U.S.C. 112 requires a written description of the invention, enablement of how to make and use it, and disclosure of the best mode contemplated by the inventor.

  7. Which document establishes the international framework under which PCT applications are filed?

    Answer: The Patent Cooperation Treaty

    The Patent Cooperation Treaty (PCT) is the international treaty that provides a unified procedure for filing patent applications in multiple member countries.